•     1 Executive Summary
o     1.1 Market overview
o     Exhibit 01: Executive Summary – Chart on Market Overview
o     Exhibit 02: Executive Summary – Data Table on Market Overview
o     Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o     Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o     Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o     Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o     Exhibit 07: Executive Summary – Chart on Incremental Growth
o     Exhibit 08: Executive Summary – Data Table on Incremental Growth
o     Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
•     2 Market Landscape
o     2.1 Market ecosystem
o     Exhibit 10: Parent market
o     Exhibit 11: Market Characteristics
•     3 Market Sizing
o     3.1 Market definition
o     Exhibit 12: Offerings of vendors included in the market definition
o     3.2 Market segment analysis
o     Exhibit 13: Market segments
o     3.3 Market size 2022
o     3.4 Market outlook: Forecast for 2022-2027
o     Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o     Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o     Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o     Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
•     4 Historic Market Size
o     4.1 Global autism spectrum disorder therapeutics market 2017 – 2021
o     Exhibit 18: Historic Market Size – Data Table on global autism spectrum disorder therapeutics market 2017 – 2021 ($ million)
o     4.2 Distribution Channel Segment Analysis 2017 – 2021
o     Exhibit 19: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o     4.3 Type Segment Analysis 2017 – 2021
o     Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o     4.4 Geography Segment Analysis 2017 – 2021
o     Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o     4.5 Country Segment Analysis 2017 – 2021
o     Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
•     5 Five Forces Analysis
o     5.1 Five forces summary
o     Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o     5.2 Bargaining power of buyers
o     Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o     5.3 Bargaining power of suppliers
o     Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o     5.4 Threat of new entrants
o     Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o     5.5 Threat of substitutes
o     Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o     5.6 Threat of rivalry
o     Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o     5.7 Market condition
o     Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
•     6 Market Segmentation by Distribution Channel
o     6.1 Market segments
o     Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o     Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o     6.2 Comparison by Distribution Channel
o     Exhibit 32: Chart on Comparison by Distribution Channel
o     Exhibit 33: Data Table on Comparison by Distribution Channel
o     6.3 Retail pharmacy – Market size and forecast 2022-2027
o     Exhibit 34: Chart on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
o     Exhibit 35: Data Table on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
o     Exhibit 36: Chart on Retail pharmacy – Year-over-year growth 2022-2027 (%)
o     Exhibit 37: Data Table on Retail pharmacy – Year-over-year growth 2022-2027 (%)
o     6.4 Hospital pharmacy – Market size and forecast 2022-2027
o     Exhibit 38: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o     Exhibit 39: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o     Exhibit 40: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o     Exhibit 41: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o     6.5 Online pharmacy – Market size and forecast 2022-2027
o     Exhibit 42: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o     Exhibit 43: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o     Exhibit 44: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
o     Exhibit 45: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
o     6.6 Market opportunity by Distribution Channel
o     Exhibit 46: Market opportunity by Distribution Channel ($ million)
o     Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
•     7 Market Segmentation by Type
o     7.1 Market segments
o     Exhibit 48: Chart on Type – Market share 2022-2027 (%)
o     Exhibit 49: Data Table on Type – Market share 2022-2027 (%)
o     7.2 Comparison by Type
o     Exhibit 50: Chart on Comparison by Type
o     Exhibit 51: Data Table on Comparison by Type
o     7.3 Stimulants – Market size and forecast 2022-2027
o     Exhibit 52: Chart on Stimulants – Market size and forecast 2022-2027 ($ million)
o     Exhibit 53: Data Table on Stimulants – Market size and forecast 2022-2027 ($ million)
o     Exhibit 54: Chart on Stimulants – Year-over-year growth 2022-2027 (%)
o     Exhibit 55: Data Table on Stimulants – Year-over-year growth 2022-2027 (%)
o     7.4 Selective serotonin reuptake inhibitors – Market size and forecast 2022-2027
o     Exhibit 56: Chart on Selective serotonin reuptake inhibitors – Market size and forecast 2022-2027 ($ million)
o     Exhibit 57: Data Table on Selective serotonin reuptake inhibitors – Market size and forecast 2022-2027 ($ million)
o     Exhibit 58: Chart on Selective serotonin reuptake inhibitors – Year-over-year growth 2022-2027 (%)
o     Exhibit 59: Data Table on Selective serotonin reuptake inhibitors – Year-over-year growth 2022-2027 (%)
o     7.5 Antipsychotic drugs – Market size and forecast 2022-2027
o     Exhibit 60: Chart on Antipsychotic drugs – Market size and forecast 2022-2027 ($ million)
o     Exhibit 61: Data Table on Antipsychotic drugs – Market size and forecast 2022-2027 ($ million)
o     Exhibit 62: Chart on Antipsychotic drugs – Year-over-year growth 2022-2027 (%)
o     Exhibit 63: Data Table on Antipsychotic drugs – Year-over-year growth 2022-2027 (%)
o     7.6 Sleep medications – Market size and forecast 2022-2027
o     Exhibit 64: Chart on Sleep medications – Market size and forecast 2022-2027 ($ million)
o     Exhibit 65: Data Table on Sleep medications – Market size and forecast 2022-2027 ($ million)
o     Exhibit 66: Chart on Sleep medications – Year-over-year growth 2022-2027 (%)
o     Exhibit 67: Data Table on Sleep medications – Year-over-year growth 2022-2027 (%)
o     7.7 Others – Market size and forecast 2022-2027
o     Exhibit 68: Chart on Others – Market size and forecast 2022-2027 ($ million)
o     Exhibit 69: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o     Exhibit 70: Chart on Others – Year-over-year growth 2022-2027 (%)
o     Exhibit 71: Data Table on Others – Year-over-year growth 2022-2027 (%)
o     7.8 Market opportunity by Type
o     Exhibit 72: Market opportunity by Type ($ million)
o     Exhibit 73: Data Table on Market opportunity by Type ($ million)
•     8 Customer Landscape
o     8.1 Customer landscape overview
o     Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
•     9 Geographic Landscape
o     9.1 Geographic segmentation
o     Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
o     Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o     9.2 Geographic comparison
o     Exhibit 77: Chart on Geographic comparison
o     Exhibit 78: Data Table on Geographic comparison
o     9.3 North America – Market size and forecast 2022-2027
o     Exhibit 79: Chart on North America – Market size and forecast 2022-2027 ($ million)
o     Exhibit 80: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o     Exhibit 81: Chart on North America – Year-over-year growth 2022-2027 (%)
o     Exhibit 82: Data Table on North America – Year-over-year growth 2022-2027 (%)
o     9.4 Europe – Market size and forecast 2022-2027
o     Exhibit 83: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o     Exhibit 84: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o     Exhibit 85: Chart on Europe – Year-over-year growth 2022-2027 (%)
o     Exhibit 86: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o     9.5 Asia – Market size and forecast 2022-2027
o     Exhibit 87: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o     Exhibit 88: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o     Exhibit 89: Chart on Asia – Year-over-year growth 2022-2027 (%)
o     Exhibit 90: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o     9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o     Exhibit 91: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o     Exhibit 92: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o     Exhibit 93: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o     Exhibit 94: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o     9.7 US – Market size and forecast 2022-2027
o     Exhibit 95: Chart on US – Market size and forecast 2022-2027 ($ million)
o     Exhibit 96: Data Table on US – Market size and forecast 2022-2027 ($ million)
o     Exhibit 97: Chart on US – Year-over-year growth 2022-2027 (%)
o     Exhibit 98: Data Table on US – Year-over-year growth 2022-2027 (%)
o     9.8 UK – Market size and forecast 2022-2027
o     Exhibit 99: Chart on UK – Market size and forecast 2022-2027 ($ million)
o     Exhibit 100: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o     Exhibit 101: Chart on UK – Year-over-year growth 2022-2027 (%)
o     Exhibit 102: Data Table on UK – Year-over-year growth 2022-2027 (%)
o     9.9 Germany – Market size and forecast 2022-2027
o     Exhibit 103: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o     Exhibit 104: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o     Exhibit 105: Chart on Germany – Year-over-year growth 2022-2027 (%)
o     Exhibit 106: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o     9.10 Canada – Market size and forecast 2022-2027
o     Exhibit 107: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o     Exhibit 108: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o     Exhibit 109: Chart on Canada – Year-over-year growth 2022-2027 (%)
o     Exhibit 110: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o     9.11 China – Market size and forecast 2022-2027
o     Exhibit 111: Chart on China – Market size and forecast 2022-2027 ($ million)
o     Exhibit 112: Data Table on China – Market size and forecast 2022-2027 ($ million)
o     Exhibit 113: Chart on China – Year-over-year growth 2022-2027 (%)
o     Exhibit 114: Data Table on China – Year-over-year growth 2022-2027 (%)
o     9.12 Market opportunity By Geographical Landscape
o     Exhibit 115: Market opportunity By Geographical Landscape ($ million)
o     Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
•     10 Drivers, Challenges, and Trends
o     10.1 Market drivers
o     10.2 Market challenges
o     10.3 Impact of drivers and challenges
o     Exhibit 117: Impact of drivers and challenges in 2022 and 2027
o     10.4 Market trends
•     11 Vendor Landscape
o     11.1 Overview
o     11.2 Vendor landscape
o     Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o     11.3 Landscape disruption
o     Exhibit 119: Overview on factors of disruption
o     11.4 Industry risks
o     Exhibit 120: Impact of key risks on business
•     12 Vendor Analysis
o     12.1 Vendors covered
o     Exhibit 121: Vendors covered
o     12.2 Market positioning of vendors
o     Exhibit 122: Matrix on vendor position and classification
o     12.3 Bristol Myers Squibb Co.
o     Exhibit 123: Bristol Myers Squibb Co. – Overview
o     Exhibit 124: Bristol Myers Squibb Co. – Product / Service
o     Exhibit 125: Bristol Myers Squibb Co. – Key news
o     Exhibit 126: Bristol Myers Squibb Co. – Key offerings
o     12.4 CureMark LLC
o     Exhibit 127: CureMark LLC – Overview
o     Exhibit 128: CureMark LLC – Product / Service
o     Exhibit 129: CureMark LLC – Key offerings
o     12.5 F. Hoffmann La Roche Ltd.
o     Exhibit 130: F. Hoffmann La Roche Ltd. – Overview
o     Exhibit 131: F. Hoffmann La Roche Ltd. – Business segments
o     Exhibit 132: F. Hoffmann La Roche Ltd. – Key news
o     Exhibit 133: F. Hoffmann La Roche Ltd. – Key offerings
o     Exhibit 134: F. Hoffmann La Roche Ltd. – Segment focus
o     12.6 Jazz Pharmaceuticals Plc
o     Exhibit 135: Jazz Pharmaceuticals Plc – Overview
o     Exhibit 136: Jazz Pharmaceuticals Plc – Product / Service
o     Exhibit 137: Jazz Pharmaceuticals Plc – Key news
o     Exhibit 138: Jazz Pharmaceuticals Plc – Key offerings
o     12.7 Les Laboratoires Servier SAS
o     Exhibit 139: Les Laboratoires Servier SAS – Overview
o     Exhibit 140: Les Laboratoires Servier SAS – Business segments
o     Exhibit 141: Les Laboratoires Servier SAS – Key offerings
o     Exhibit 142: Les Laboratoires Servier SAS – Segment focus
o     12.8 Neurim Pharmaceuticals Ltd.
o     Exhibit 143: Neurim Pharmaceuticals Ltd. – Overview
o     Exhibit 144: Neurim Pharmaceuticals Ltd. – Product / Service
o     Exhibit 145: Neurim Pharmaceuticals Ltd. – Key offerings
o     12.9 Novartis AG
o     Exhibit 146: Novartis AG – Overview
o     Exhibit 147: Novartis AG – Business segments
o     Exhibit 148: Novartis AG – Key offerings
o     Exhibit 149: Novartis AG – Segment focus
o     12.10 Oryzon Genomics SA
o     Exhibit 150: Oryzon Genomics SA – Overview
o     Exhibit 151: Oryzon Genomics SA – Product / Service
o     Exhibit 152: Oryzon Genomics SA – Key offerings
o     12.11 Otsuka Holdings Co. Ltd.
o     Exhibit 153: Otsuka Holdings Co. Ltd. – Overview
o     Exhibit 154: Otsuka Holdings Co. Ltd. – Business segments
o     Exhibit 155: Otsuka Holdings Co. Ltd. – Key offerings
o     Exhibit 156: Otsuka Holdings Co. Ltd. – Segment focus
o     12.12 Q BioMed Inc.
o     Exhibit 157: Q BioMed Inc. – Overview
o     Exhibit 158: Q BioMed Inc. – Product / Service
o     Exhibit 159: Q BioMed Inc. – Key offerings
o     12.13 Scioto Biosciences Inc.
o     Exhibit 160: Scioto Biosciences Inc. – Overview
o     Exhibit 161: Scioto Biosciences Inc. – Product / Service
o     Exhibit 162: Scioto Biosciences Inc. – Key offerings
o     12.14 Spectrum Pharmaceuticals Inc.
o     Exhibit 163: Spectrum Pharmaceuticals Inc. – Overview
o     Exhibit 164: Spectrum Pharmaceuticals Inc. – Product / Service
o     Exhibit 165: Spectrum Pharmaceuticals Inc. – Key offerings
o     12.15 Stalicla SA
o     Exhibit 166: Stalicla SA – Overview
o     Exhibit 167: Stalicla SA – Product / Service
o     Exhibit 168: Stalicla SA – Key offerings
o     12.16 Yamo Pharmaceuticals LLC
o     Exhibit 169: Yamo Pharmaceuticals LLC – Overview
o     Exhibit 170: Yamo Pharmaceuticals LLC – Product / Service
o     Exhibit 171: Yamo Pharmaceuticals LLC – Key offerings
o     12.17 Zynerba Pharmaceuticals Inc.
o     Exhibit 172: Zynerba Pharmaceuticals Inc. – Overview
o     Exhibit 173: Zynerba Pharmaceuticals Inc. – Product / Service
o     Exhibit 174: Zynerba Pharmaceuticals Inc. – Key offerings
•     13 Appendix
o     13.1 Scope of the report
o     13.2 Inclusions and exclusions checklist
o     Exhibit 175: Inclusions checklist
o     Exhibit 176: Exclusions checklist
o     13.3 Currency conversion rates for US$
o     Exhibit 177: Currency conversion rates for US$
o     13.4 Research methodology
o     Exhibit 178: Research methodology
o     Exhibit 179: Validation techniques employed for market sizing
o     Exhibit 180: Information sources
o     13.5 List of abbreviations
o     Exhibit 181: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global autism spectrum disorder therapeutics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Retail pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Retail pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Type – Market share 2022-2027 (%)
Exhibits49: Data Table on Type – Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Stimulants – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Stimulants – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Stimulants – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Stimulants – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Selective serotonin reuptake inhibitors – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Selective serotonin reuptake inhibitors – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Selective serotonin reuptake inhibitors – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Selective serotonin reuptake inhibitors – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Antipsychotic drugs – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Antipsychotic drugs – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Antipsychotic drugs – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Antipsychotic drugs – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Sleep medications – Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Sleep medications – Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Sleep medications – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Sleep medications – Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits69: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits70: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits72: Market opportunity by Type ($ million)
Exhibits73: Data Table on Market opportunity by Type ($ million)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ million)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits117: Impact of drivers and challenges in 2022 and 2027
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Bristol Myers Squibb Co. – Overview
Exhibits124: Bristol Myers Squibb Co. – Product / Service
Exhibits125: Bristol Myers Squibb Co. – Key news
Exhibits126: Bristol Myers Squibb Co. – Key offerings
Exhibits127: CureMark LLC – Overview
Exhibits128: CureMark LLC – Product / Service
Exhibits129: CureMark LLC – Key offerings
Exhibits130: F. Hoffmann La Roche Ltd. – Overview
Exhibits131: F. Hoffmann La Roche Ltd. – Business segments
Exhibits132: F. Hoffmann La Roche Ltd. – Key news
Exhibits133: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits135: Jazz Pharmaceuticals Plc – Overview
Exhibits136: Jazz Pharmaceuticals Plc – Product / Service
Exhibits137: Jazz Pharmaceuticals Plc – Key news
Exhibits138: Jazz Pharmaceuticals Plc – Key offerings
Exhibits139: Les Laboratoires Servier SAS – Overview
Exhibits140: Les Laboratoires Servier SAS – Business segments
Exhibits141: Les Laboratoires Servier SAS – Key offerings
Exhibits142: Les Laboratoires Servier SAS – Segment focus
Exhibits143: Neurim Pharmaceuticals Ltd. – Overview
Exhibits144: Neurim Pharmaceuticals Ltd. – Product / Service
Exhibits145: Neurim Pharmaceuticals Ltd. – Key offerings
Exhibits146: Novartis AG – Overview
Exhibits147: Novartis AG – Business segments
Exhibits148: Novartis AG – Key offerings
Exhibits149: Novartis AG – Segment focus
Exhibits150: Oryzon Genomics SA – Overview
Exhibits151: Oryzon Genomics SA – Product / Service
Exhibits152: Oryzon Genomics SA – Key offerings
Exhibits153: Otsuka Holdings Co. Ltd. – Overview
Exhibits154: Otsuka Holdings Co. Ltd. – Business segments
Exhibits155: Otsuka Holdings Co. Ltd. – Key offerings
Exhibits156: Otsuka Holdings Co. Ltd. – Segment focus
Exhibits157: Q BioMed Inc. – Overview
Exhibits158: Q BioMed Inc. – Product / Service
Exhibits159: Q BioMed Inc. – Key offerings
Exhibits160: Scioto Biosciences Inc. – Overview
Exhibits161: Scioto Biosciences Inc. – Product / Service
Exhibits162: Scioto Biosciences Inc. – Key offerings
Exhibits163: Spectrum Pharmaceuticals Inc. – Overview
Exhibits164: Spectrum Pharmaceuticals Inc. – Product / Service
Exhibits165: Spectrum Pharmaceuticals Inc. – Key offerings
Exhibits166: Stalicla SA – Overview
Exhibits167: Stalicla SA – Product / Service
Exhibits168: Stalicla SA – Key offerings
Exhibits169: Yamo Pharmaceuticals LLC – Overview
Exhibits170: Yamo Pharmaceuticals LLC – Product / Service
Exhibits171: Yamo Pharmaceuticals LLC – Key offerings
Exhibits172: Zynerba Pharmaceuticals Inc. – Overview
Exhibits173: Zynerba Pharmaceuticals Inc. – Product / Service
Exhibits174: Zynerba Pharmaceuticals Inc. – Key offerings
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			